Dr. Jeffrey Peter Yourshaw, MD

Dr. Yourshaw practices at MUSC University Hospital in Charleston, South Carolina.

Dr. Yourshaw's NPI, 1003109869, was assigned on May 25, 2011. Dr. Yourshaw graduated from Pennsylvania State University College of Medicine in 2011. Dr. Yourshaw holds South Carolina license 37854.

Dr. Yourshaw's primary practice is MUSC University Hospital, at 171 Ashley Ave, Charleston, SC 29425 in Charleston County. The practice phone is (843) 792-1414.

Dr. Yourshaw's primary practice is MUSC University Hospital in Charleston, South Carolina. Dr. Yourshaw is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Atrium Health Wake Forest Baptist. Dmand AI also links Dr. Yourshaw to 2 more hospitals, 8 medical groups and 6 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yourshaw practices, 9 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Yourshaw's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Yourshaw is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Yourshaw's licenses on file in 2 states: South Carolina and Pennsylvania.

CMS data shows 1,185 Medicare services from Dr. Yourshaw across 20 procedure codes in 2024, for 664 Medicare patients. Medicare paid $94,913 for them.

CMS counts 664 Medicare patients who saw Dr. Yourshaw in 2024. The largest group is 65 to 74, with 270 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yourshaw's median patient age at 74, with 51% women.

In 2024, Dr. Yourshaw wrote 349 Medicare Part D claims for 67 patients. 83% of them were for generic drugs. CMS names the drug for 236 of them, across 12 drugs with 11 or more claims each, at $29,417 in total drug cost. In 2023, CMS named 239 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Yourshaw for performance year 2024, reported as part of a group. Dr. Yourshaw accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of coronary angioplasty and stenting by Dr. Yourshaw, more than 33% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Yourshaw, published from 2018 to 2025. 2024 was the busiest year, with 2. The most frequent topics are Heart-Assist Devices and Heart Failure. Dr. Yourshaw's most frequent co-authors are Anthony Philip Carnicelli, MD, Brian Allan Houston, MD and Ryan James Tedford, MD.

CMS Open Payments shows 173 general payments to Dr. Yourshaw from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 74% of the total. Abbott Laboratories paid the most, $3,190.

Dr. Yourshaw graduated from Pennsylvania State University College of Medicine in 2011.